Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer entities : Orange save search
Philadelphia Phillies partner with the National Pediatric Cancer Foundation® for "Cut and Color Funds the Cure®"
Published: 2024-03-23 (Crawled : 00:20) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
foundation cancer
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
MRK | $127.0 0.1% 2.37% 62K
|
Health Technology
|
| O: -0.13%
H: 0.4%
C: -0.06%
ylynk-006 keytruda lung merck update cancer cell trial plus
Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine (CIRM) to Advance CLD-101 (NeuroNova) in Ovarian Cancer
Published: 2024-03-11 (Crawled : 12:30) - biospace.com/
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
cld-101 california institute hope cancer city funding
No Solution in Sight, Florida Cancer Specialists & Research Institute, Core Ventures Forge Ahead in Race to Recover from Change Healthcare Shutdown
Published: 2024-03-08 (Crawled : 22:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
change solution cancer research
Florida Cancer Specialists & Research Institute Implements Contingency Plan to Overcome National Clearinghouse Outage
Published: 2024-03-07 (Crawled : 23:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
institute cancer research
Lyre's Non-Alcoholic & Ezy Raise Launch the inaugural "Dry Feb™️" Fundraising Challenge to Benefit American Cancer Society
Published: 2024-01-31 (Crawled : 00:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
cancer
Hollywood's Portrayal of Cancer in Movies Fuels Misconceptions, New Study Finds
Published: 2024-01-17 (Crawled : 16:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
cancer study
City of Hope Predicts 8 Important Cancer Trends in 2024
Published: 2024-01-17 (Crawled : 15:00) - biospace.com/
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
hope cancer city trends
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
MRK | $127.0 0.1% 2.37% 62K
|
Health Technology
|
| O: -0.04%
H: 0.01%
C: -1.61%
ylynk-008 keytruda lung merck cancer cell trial plus
Gastric Cancer Diagnostic Market to Reach $3.8 Billion, Globally, by 2032 at 5.3% CAGR: Allied Market Research
Published: 2023-11-10 (Crawled : 15:30) - prnewswire.com
BIO | $278.21 -2.48% 0.0% 1
|
Health Technology
|
| O: -0.27%
H: 0.44%
C: -0.63%
A | $135.485 -1.46% 43K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
ABT | News | $106.76 -0.12% 150K
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
EXAS | $60.015 -5.1% 260K
|
Health Technology
|
| O: -0.23%
H: 1.53%
C: 0.44%
diagnostic reach cancer research market
OneOncology Partners with Mid Florida Cancer Centers
Published: 2023-11-09 (Crawled : 12:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
cancer
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2023-11-04 (Crawled : 12:20) - globenewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
gda-201 candidate natural cancer cell immunotherapy meeting therapy
This Breast Cancer Awareness month, know the signs and symptoms of an aggressive cancer that cannot be detected by feeling for lumps
Published: 2023-10-26 (Crawled : 17:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
breast cancer
BENEV Company Inc. Joins Forces with Image Reborn to Support Breast Cancer Survivors at the Fire & Ice Gala
Published: 2023-10-23 (Crawled : 17:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
company breast cancer ice
Valvoline Instant Oil Change Locations Raise Funds for the Fight Against Cancer
Published: 2023-10-19 (Crawled : 15:00) - globenewswire.com
VVV | $42.61 9.5K
|
Process Industries
|
| O: -0.41%
H: 0.98%
C: -1.68%
change cancer oil
Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease
Published: 2023-10-10 (Crawled : 11:00) - biospace.com/
MRK | $127.0 0.1% 2.37% 62K
|
Health Technology
|
| O: -0.17%
H: 0.13%
C: -0.68%
disease congress merck cancer pipeline research
City of Hope Opens First U.S. Multicenter Clinical Trial for Robotic Single-Port Mastectomies for Breast Cancer Patients
Published: 2023-10-03 (Crawled : 16:00) - biospace.com/
FNCTF | News | $11.16 1.13% 0
|
Communications
| Email alert
Add to watchlist
breast hope cancer city trial
Valvoline Instant Oil Change Locations Raise Funds for the Fight Against Cancer
Published: 2023-09-28 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
|
| O: 0.22%
H: 0.0%
C: 0.0%
VVV | $42.61 9.5K
|
Process Industries
|
| O: 0.03%
H: 0.87%
C: 0.19%
change cancer oil
Hoag to Offer Technology to Detect Lung Cancer Earlier and More Accurately
Published: 2023-09-06 (Crawled : 19:00) - prnewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
|
| O: 5.1%
H: 0.0%
C: 0.0%
lung cancer technology
Eagle Pharmaceuticals Announces Positive Type C Meeting with FDA for EA-114, an Estrogen Receptor Antagonist Used in the Treatment of Metastatic Breast Cancer in Post-Menopausal Women
Published: 2023-08-29 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.16 1.13% 0
|
Communications
|
| O: 1.76%
H: 0.0%
C: 0.0%
EGRX | $4.55 -4.61% -4.15% 0
|
Health Technology
|
| O: 0.49%
H: 3.15%
C: 2.79%
ea-114 fda breast positive cancer treatment pharmaceuticals women meeting
Gainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
BOF | $1.915 63.68% 620K
|
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
AIXI | $1.34 8.94% 42K
|
n/a
TRU | $74.475 8.44% 100K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.